carvedilol has been researched along with 2019 Novel Coronavirus Disease in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The former dosage of ACEis/ARBs was continued in one group while in another group, the ACEis/ARBs were replaced by amlodipine ± carvedilol according to the dose equivalents." | 3.01 | Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial. ( Ashraf, H; Bahreini, M; Ghoghaei, M; Najmeddin, F; Rasooli, F; Salehi, M; Soleimani, A; Solhjoo, M, 2021) |
| "The pandemic of coronavirus disease 2019 (COVID-19) caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a significant impact on the economy and public health worldwide." | 1.91 | In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches. ( Liu, J; Liu, S; Sui, Y; Yang, M; Zhang, C, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Onohuean, H | 1 |
| Al-Kuraishy, HM | 1 |
| Al-Gareeb, AI | 1 |
| Qusti, S | 1 |
| Alshammari, EM | 1 |
| Batiha, GE | 1 |
| Zhang, C | 1 |
| Liu, J | 1 |
| Sui, Y | 1 |
| Liu, S | 1 |
| Yang, M | 1 |
| Skayem, C | 1 |
| Ayoub, N | 1 |
| Vasanthakumar, N | 1 |
| Najmeddin, F | 1 |
| Solhjoo, M | 1 |
| Ashraf, H | 1 |
| Salehi, M | 1 |
| Rasooli, F | 1 |
| Ghoghaei, M | 1 |
| Soleimani, A | 1 |
| Bahreini, M | 1 |
1 review available for carvedilol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Covid-19 and development of heart failure: mystery and truth.
Topics: Adrenergic alpha-1 Receptor Antagonists; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Cardioton | 2021 |
1 trial available for carvedilol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.
Topics: Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; | 2021 |
3 other studies available for carvedilol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches.
Topics: Antiviral Agents; Carvedilol; COVID-19; Drug Repositioning; Humans; Molecular Docking Simulation; Mo | 2023 |
Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2.
Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Carvedil | 2020 |
Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme 2; Betacoronavirus; Carvedilol; Coronavir | 2020 |